Hereditary hemochromatosis in the post‐HFE era

John K. Olynyk, Debbie Trinder, Grant A. Ramm, Robert S. Britton, Bruce R. Bacon – 16 July 2008 – Following the discovery of the HFE gene in 1996 and its linkage to the iron overload disorder hereditary hemochromatosis (HH) there have been profound developments in our understanding of the pathogenesis of the biochemical and clinical manifestations of a number of iron overload disorders.

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large‐volume center

Sung‐Gyu Lee, Shin Hwang, Deok‐Bog Moon, Chul‐Soo Ahn, Ki‐Hun Kim, Kyu‐Bo Sung, Gi‐Young Ko, Kwang‐Min Park, Tae‐Yong Ha, Gi‐Won Song – 25 June 2008 – The currently available indication criteria of living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC) have high prognostic power but insufficient discriminatory power. On the basis of single‐center results from 221 HCC patients undergoing LDLT, we modified the indication criteria for LDLT to expand recipient selection without increasing the posttransplant recurrence of HCC.

Subscribe to